Thursday, October 23, 2025

11:10 AM - 11:55 AM

Momentum Room

---

Details

During a period of global change, Australia is increasingly recognised as a stable destination for high-quality clinical development and advanced manufacturing. With streamlined trial approvals, world-class researchers, universal healthcare systems, and trusted regulatory standards, the ecosystem is well placed to support generation of robust data quickly and efficiently. At the same time, Australia’s expanding network of cGMP / GMP facilities and collaborative ecosystem provide reliable capacity from clinical supply through to commercial production. All enabled by attractive R&D tax incentives and strategically positioned in the Asia-Pacific region. In this keynote, Daniel will explore why international companies are increasingly turning their eyes to Australia and why the time is now for Australia to play to its inherent strengths.

---

Speaker